tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
US Market

Capricor Therapeutics (CAPR) Income Statement

Compare
1,275 Followers

Capricor Therapeutics Income Statement

Last quarter (Q4 2025), Capricor Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Capricor Therapeutics's net income was $-30.17M. See Capricor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 22.27M$ 25.18M$ 2.55M$ 244.90K
Gross Profit
$ 0.00$ -27.70M$ -11.27M$ -19.27M$ 244.90K
Operating Expenses
$ 108.14M$ 14.87M$ 12.81M$ 10.43M$ 21.18M
Depreciation and Amortization
$ 0.00$ 1.43M$ 1.07M$ 533.13K$ 245.70K
EBITDA
$ -108.14M$ -41.14M$ -23.01M$ -29.16M$ -20.69M
Operating Income
$ -108.14M$ -42.56M$ -24.08M$ -29.70M$ -20.94M
Other Income/Expenses
$ 3.10M$ 2.10M$ 1.79M$ 677.85K$ 915.92K
Pretax Income
$ -105.04M$ -40.47M$ -22.29M$ -29.02M$ -20.02M
Net Income
$ -105.04M$ -40.47M$ -22.29M$ -29.02M$ -20.02M
Per Share Metrics
Basic EPS
$ -2.26$ -1.15$ -0.83$ -1.18$ -0.87
Diluted EPS
$ -2.26$ -1.15$ -0.83$ -1.18$ -0.87
Weighted Average Shares Outstanding
46.48M 35.22M 26.78M 24.55M 23.09M
Weighted Average Shares Outstanding (Diluted)
46.48M 35.22M 26.78M 24.55M 23.09M
Currency in USD

Capricor Therapeutics Earnings and Revenue History